TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

TELA Bio

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that it was recently awarded a group purchasing agreement for Synthetic Bioabsorbable Mesh Products with Premier, Inc. Effective October 1st, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OviTex® and OviTex PRS Reinforced Tissue Matrix.

Premier (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 225,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.

“We are both grateful and honored to be awarded this important agreement,” said Antony Koblish, President and CEO of TELA Bio. “This is a significant opportunity for our company, and we look forward to working with Premier members to provide their surgeons and patients with access to our advanced soft-tissue repair portfolio.”

READ:  Ocugen To Host Conference Call on Friday

OviTex and OviTex PRS Reinforced Tissue Matrix are a next generation soft tissue repair platform for use in general, plastic and reconstructive surgery. OviTex utilizes layers of naturally sourced tissue interwoven with permanent or resorbable polymer suture to facilitate tissue remodeling, optimize strength, and minimize permanent synthetic foreign body footprint. To learn more, please visit www.telabio.com/ovitex.html.

Related Articles

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.